Notatki do odcinka
Second Order Conversations, Episode 01: Jeff Liu, CEO & Co-founder of FinalDose
A tumor analysis can list the mutations a cancer carries. FinalDose is asking whether a mutation can do more than describe the disease. The company wants to use it as an address: a DNA sequence that a therapy reads, finds, and acts on.
FinalDose was founded in 2025 by Jeff Liu, Ph.D. (CEO & Co-founder), Li-Yao Huang, Ph.D. (Chief Scientific Officer), Steven Lin, Ph.D. (Chief Technology Officer). All three are based in London. All three hold Oxford doctorates, in oncology, biochemistry, and computational biology…
Strona: secondordernarrative.substack.com

